Near-Infrared Light Devices Versus Landmark Approach for Peripheral Venous Access in Intensive Care Unit
Launched by CENTRE HOSPITALIER RÉGIONAL D'ORLÉANS · Jan 29, 2024
Trial Information
Current as of July 07, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods for placing a peripheral intravenous catheter (PIVC) in critically ill patients who have already had a central venous catheter (CVC) removed. The researchers want to see if using a near-infrared light device (NILD), which helps nurses see veins more clearly on the skin, can improve the success rate of the first attempt at inserting the PIVC compared to the traditional method of finding veins by touch and sight. This is important because many ICU patients develop swelling in their arms, making it harder to find veins for IV access.
To participate in the study, patients must be at least 18 years old, currently hospitalized in the ICU, and have a CVC that is no longer needed. Some patients may not be eligible if they have certain medical conditions or if their arms have tattoos covering most of the skin. If they decide to join, participants can expect to have their veins examined using both methods, and the results will help improve care for critically ill patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥18 years old
- • Hospitalized in ICU
- • with a deep venous catheter (jugular, subclavian or femoral)
- • In whom the use of a deep venous line is no longer justified (absence of: vasopressor amines, chemotherapy, parenteral nutrition, hypertonic solutions)
- Exclusion Criteria:
- • Absolute contraindication or anatomical impossibility to perform a PIVC on the upper limbs
- • Patient already included in the study
- • Tattoo covering most of both forearms
- • Adult subject to a legal protection measure (guardianship, curators, person under court protection)
- • Persons deprived of their liberty by a judicial or administrative decision, persons hospitalised without consent and persons admitted to a health or social establishment for purposes other than research.
- • Pregnant or breast-feeding woman
About Centre Hospitalier Régional D'orléans
The Centre Hospitalier Régional d'Orléans is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Orléans, France, the center is committed to fostering a collaborative environment that integrates clinical expertise with cutting-edge research methodologies. By facilitating multidisciplinary studies across various therapeutic areas, the Centre Hospitalier Régional d'Orléans aims to enhance treatment protocols and contribute to the global body of medical knowledge, ultimately benefiting patients and the healthcare community at large.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Le Mans, , France
Tours, , France
Chartres, , France
Orléans, , France
Patients applied
Trial Officials
Aude FERRIER
Principal Investigator
CHU Orléans
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported